Prinomastat Plus Temozolomide Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Prinomastat may stop the growth of glioblastoma multiforme by stopping blood flow
to the tumor. Drugs used in chemotherapy stop tumor cells from dividing so they stop growing
or die.
PURPOSE: Randomized phase II trial to study the effectiveness of prinomastat plus
temozolomide in treating patients who have newly diagnosed glioblastoma multiforme.